Finn, R. S., Ikeda, M., Zhu, A. X., Sung, M. W., Baron, A. D., Kudo, M., . . . Llovet, J. M. (2020). Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma. J Clin Oncol.
Style de citation ChicagoFinn, Richard S., et al. "Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma." J Clin Oncol 2020.
Style de citation MLAFinn, Richard S., et al. "Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma." J Clin Oncol 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.